Ketorolac Tromethamine Injection — FDA Drug Shortage

Current — Gland Pharma Limited

The FDA lists a drug shortage record for Ketorolac Tromethamine Injection (injection) from Gland Pharma Limited with status Current. The shortage was first posted on Jun 6, 2018.

Shortage details

Status
Current
Company
Gland Pharma Limited
Package NDC
72266-118-25
Dosage Form
Injection
Presentation
Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-118-25)
Initial Posting
Jun 6, 2018

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.